Login / Signup

The intensity of anticoagulant dosing in hospitalized patients with COVID-19: An observational, comparative effectiveness study.

Laura C MyersStanley XuAiyu ChenJohn D GreeneBeth CreekmurKatia J BruxvoortGabriel J EscobarJohn L AdamsAnnette Langer-GouldVincent X LiuMichael K Gould
Published in: Journal of hospital medicine (2022)
Results of this real-world, comparative effectiveness study showed no differences in in-hospital death among newly admitted or deteriorating patients with COVID-19 who received intermediate-dose or full anticoagulation compared with standard prophylaxis.
Keyphrases
  • atrial fibrillation
  • healthcare
  • high intensity
  • electronic health record
  • adverse drug